| Dr Kevin Nelson Murat, DC, ATC | |
|
75 Selleck St, Stamford, CT 06902-7207 | |
| (203) 149-6356 | |
| Not Available |
| Full Name | Dr Kevin Nelson Murat |
|---|---|
| Gender | Male |
| Speciality | Specialist/technologist - Athletic Trainer |
| Location | 75 Selleck St, Stamford, Connecticut |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194223057 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 111N00000X | Chiropractor | 2185 (Connecticut) | Secondary |
| 2255A2300X | Specialist/technologist - Athletic Trainer | 001066 (Connecticut) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kevin Nelson Murat, DC, ATC 2289 Bedford St Unit D7, Stamford, CT 06905-3911 Ph: (203) 816-7073 | Dr Kevin Nelson Murat, DC, ATC 75 Selleck St, Stamford, CT 06902-7207 Ph: (203) 149-6356 |
News Archive
In hopes of combating the growing scourge of antibiotic-resistant bacteria, in particular drug-resistant staph bacteria, a team of scientists from the Scripps Research Institute has designed a new type of vaccine that could one day be used in humans to block the onset of infection.
The American Association for Dental Research (AADR) has announced David C. Johnsen, dean of the College of Dentistry, University of Iowa, as the recipient of the 2010 AADR Jack Hein Public Service Award. This award will be presented to Johnsen at the 39th AADR Annual Meeting & Exhibition in Washington, DC, March 3, 2010.
PuriCore, the water-based clean technology company focused on developing and commercializing proprietary, green solutions that safely, effectively, and naturally kill infectious pathogens, today issued its Interim Management Statement covering the period January 1, 2010, to March 31, 2010.
Ampio Pharmaceuticals, Inc., a company that discovers and develops new uses for previously approved drugs and new molecular entities, today announced receipt of notification of the granting of a European patent with broad claims directed to compositions containing DA-DKP, a cyclic dipeptide diketopiperazine which is the active ingredient of Ampion™.
Researchers have found that a small fragment of the genetic code that has been inherited by modern humans from Neanderthals could carry the secret of why some people succumb to a severe form of COVID-19 requiring hospitalization, while others recover.
› Verified 9 days ago